Global marine microbial diversity and its potential in bioprospecting
2024 · Nature · 128 citations
https://doi.org/10.1038/s41586-024-07891-2
Y
Yue Zheng
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
142
Papers
957
Citations
17
h-index
23
i10-index
Yue Zheng is an academic researcher from Tongji University. The author has contributed to research in topics: Immune cells in cancer & Cell Adhesion Molecules Research & Neutrophil, Myeloperoxidase and Oxidative Mechanisms. The author has an h-index of 17, co-authored 121 publications.
ORCID: 0000-0002-2294-813XPapers by this author
worksAssociation of Local Therapy With Quality-of-Life Outcomes in Young Women With Breast Cancer
2021 · JAMA Surgery · 50 citations
https://doi.org/10.1001/jamasurg.2021.3758
Adjuvant Trastuzumab Emtansine Versus Paclitaxel Plus Trastuzumab for Stage I Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: 5-Year Results and Correlative Analyses From ATEMPT
2024 · Journal of Clinical Oncology · 34 citations
https://doi.org/10.1200/jco.23.02170
When to Introduce Three-Dimensional Visualization Technology into Surgical Residency: A Randomized Controlled Trial
2019 · Journal of Medical Systems · 20 citations
https://doi.org/10.1007/s10916-019-1157-0
Cardiac outcomes of subjects on adjuvant trastuzumab emtansine vs paclitaxel in combination with trastuzumab for stage I HER2-positive breast cancer (ATEMPT) study (TBCRC033): a randomized controlled trial
2022 · npj Breast Cancer · 15 citations
https://doi.org/10.1038/s41523-022-00385-2
Treatment discontinuation, patient-reported toxicities and quality-of-life by age following trastuzumab emtansine or paclitaxel/trastuzumab (ATEMPT)
2022 · npj Breast Cancer · 10 citations
https://doi.org/10.1038/s41523-022-00495-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat